Pharma Surge
Pharma Surge
Intelligence Layer

News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Regulators

01

Regulatory Updates

FDA, EMA, PMDA, MHRA, and global regulatory coverage in one crawlable hub.

Open hub

Trials

02

Clinical Trial Watch

Phase readouts, trial design updates, enrollment milestones, and study results.

Open hub

Pipeline

03

Drug Pipeline

Regulatory pipeline signals, approvals, and market-moving development updates.

Open hub
Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

2x

daily refresh

Coverage

Latest indexed stories

9,493 stories indexed, page 141 of 159

🇬🇧Industrycongenica.com
Featured signal

Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer

Publisher

Congenica

Limited excerpt on-platform. Click anywhere on this card to open the original publisher in a new tab.

CongenicaOriginal publisher link

Canonical metadata stays public, while full text remains on the original site.

🇬🇧Industrycongenica.com

Clinical and Molecular Spectrum of Nonsyndromic Early-Onset Osteoarthritis

CongenicaOriginal source
🇬🇧Industrycongenica.com

Transforming Patient Care: SeqOne Empowers CHU de Reims with Advanced Genomic Analysis

CongenicaOriginal source
🇬🇧Industrycongenica.com

Beyond the Exome: How One Lab is Democratizing Whole Genome Sequencing in Eastern Europe

CongenicaOriginal source
🇬🇧Industrycongenica.com

Precision Medicine at Scale: AP-HM’s Automated Exome Analysis Success Story

CongenicaOriginal source
🇬🇧Industrycongenica.com

AI in Clinical Genomics: The Science and Real-World Impact of AI on Variant Interpretation

CongenicaOriginal source
🇬🇧Industrycongenica.com

SeqOne Blog | Insights on AI-Powered Genomic Analysis & Clinical Innovation

CongenicaOriginal source
🇬🇧Industrycongenica.com

SeqOne | Hébergement Données Santé

CongenicaOriginal source
🇬🇧Industrycongenica.com

Cookie policy

CongenicaOriginal source
🇬🇧Industrycongenica.com

Congenica | Clinical Genomic Interpretation Platform

CongenicaOriginal source
🇪🇸Researchcnio.es

WISE -

CNIO (Spanish Cancer Research)Original source
🇪🇸Researchcnio.es

Videos -

CNIO (Spanish Cancer Research)Original source
🇪🇸Researchcnio.es

Translational -

CNIO (Spanish Cancer Research)Original source
🇪🇸Researchcnio.es

Outreach to Society -

CNIO (Spanish Cancer Research)Original source
🇪🇸Researchcnio.es

Innovation -

CNIO (Spanish Cancer Research)Original source
🇪🇸Researchcnio.es

CNIO Friends Newsletter -

CNIO (Spanish Cancer Research)Original source
🇪🇸Researchcnio.es

CNIO News -

CNIO (Spanish Cancer Research)Original source
🇪🇸Researchcnio.es

CNIO Friends -

CNIO (Spanish Cancer Research)Original source
🇪🇸Researchcnio.es

CNIO Alumni -

CNIO (Spanish Cancer Research)Original source
🇪🇸Researchcnio.es

Basic Research -

CNIO (Spanish Cancer Research)Original source
🌍Researchclevelandclinicabudhabi.ae

Media Center: Latest News & Press Releases

Cleveland Clinic Abu DhabiOriginal source
🇯🇵CDMOchugai-pharm.co.jp

Jun 19,2026 | Chugai Files New Drug Application in Japan for Sparsentan for the Treatment of IgA Nephropathy | News | CHUGAI PHARMACEUTICAL CO., LTD.

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jp

Jun 19,2026 | Avastin Receives Approval for Additional Indication as the World’s First Treatment for Neurofibromatosis Type 2 | News | CHUGAI PHARMACEUTICAL CO., LTD.

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jp

Anti-CD20 Monoclonal Antibody Rituxan ® Approved for Adult-onset Frequently Relapsing or Steroid-dependent Nephrotic Syndrome

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jp

Jun 12,2026 | Tecentriq Filed for Additional Indication as Maintenance Therapy Following Definitive Chemoradiotherapy in Locally Advanced Esophageal Cancer | News | CHUGAI PHARMACEUTICAL CO., LTD.

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jp

May 26,2026 | Chugai Receives “The Imperial Invention Prize,” the Highest Honor of the FY2026 National Commendation for Invention — Recycling Antibody Technology Recognized for its Contribution to Pharmaceutical Research — | News | CHUGAI PHARMACEUTICAL CO., LTD.

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jp

May 25,2026 | Organizational and Personnel Changes | News | CHUGAI PHARMACEUTICAL CO., LTD.

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jp

Alecensa Receives the World-First Tumor-Agnostic Approval for ALK Fusion Gene-Positive Solid Tumors Across Adult and Pediatric Patients

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jp

Chugai Obtains Approval for FoundationOne CDx Cancer Genomic Profile as a Companion Diagnostic of Alecensa for ALK Fusion Gene-Positive Solid Tumors

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jp

Filing of Humanized Anti-CD20 Monoclonal Antibody Gazyva for Additional Indication of Idiopathic Nephrotic Syndrome

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jp

May 11,2026 | Chugai’s Pharmaceutical Packaging Leveraging Proprietary Technologies Wins the “WorldStar Winner 2026” at the “WorldStar Global Packaging Awards 2026” from the World Packaging Organization | News | CHUGAI PHARMACEUTICAL CO., LTD.

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jp

Apr 24,2026 | Chugai Announces 2026 1st Quarter Results | News | CHUGAI PHARMACEUTICAL CO., LTD.

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jp

Apr 24,2026 | Organizational and Personnel Changes | News | CHUGAI PHARMACEUTICAL CO., LTD.

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jp

Determination of Details Regarding Share Acquisition Associated with the Introduction of the Trust-Based Stock Compensation System

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jp

F. Hoffmann-La Roche Announces First Quarter Sales 2026

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jp

Apr 22,2026 | FJ3, API Manufacturing Building for Small Molecule and Macrocyclic Peptide Drugs at the Fujieda Plant, Receives the 2026 Facility of the Year Awards from ISPE in the Honorable Mention Category | News | CHUGAI PHARMACEUTICAL CO., LTD.

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jp

Roche’s Announcement Regarding New Data of Enspryng for Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jp

Apr 10,2026 | Chugai Selected as “Digital Transformation Stocks (DX Stocks) 2026” | News | CHUGAI PHARMACEUTICAL CO., LTD.

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jp

Announcement of Termination of Co-Promotion of Rituxan ® in Japan (Anti-CD20 Monoclonal Antibody)

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jp

Apr 06,2026 | Research Results on Immune Thrombocytopenia from a Joint Study with Osaka University’s IFReC Published in Blood | News | CHUGAI PHARMACEUTICAL CO., LTD.

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jp

Lilly’s Announcement Regarding Oral GLP-1 Foundayo™ (Orforglipron)

Chugai PharmaceuticalOriginal source
🇩🇪Researchcharite.de

RSS Feed: Charité – Universitätsmedizin Berlin

Charité – Universitätsmedizin BerlinOriginal source
🇩🇪Researchcharite.de

Leichte Sprache: Charité – Universitätsmedizin Berlin

Charité – Universitätsmedizin BerlinOriginal source
🇩🇪Researchcharite.de

Alle Kliniken/Zentren anzeigen

Charité – Universitätsmedizin BerlinOriginal source
🇩🇪Researchcharite.de

51: 01-2 ClinicExpertFinder: Charité – Universitätsmedizin Berlin

Charité – Universitätsmedizin BerlinOriginal source
🇩🇪Researchcharite.de

Teaching & Learning: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source
🇩🇪Researchcharite.de

Press reports: Charité – Universitätsmedizin Berlin

Charité – Universitätsmedizin BerlinOriginal source
🇩🇪Researchcharite.de

51: 01-2 ClinicExpertFinder: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source
🇩🇪Researchcharite.de

Display all Departments / Centers

Charité Mitte (Berlin)Original source
🇩🇪Researchcharite.de

Fifteen Charité researchers among the top influencers in science: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source
🇩🇪Researchcharite.de

Research: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source
🇩🇪Researchcharite.de

International: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source
🇩🇪Researchcharite.de

Deutsches Herzzentrum der Charité (DHZC): Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source
🇩🇪Researchcharite.de

Emergency medicine / Central emergency rooms: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source
🇩🇪Researchcharite.de

Information for patients and families: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source
🇩🇪Researchcharite.de

Book appointments: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source
🇩🇪Researchcharite.de

Clinical Center: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source
🇩🇪Researchcharite.de

Campus Virchow-Klinikum (CVK)

Charité Mitte (Berlin)Original source
🇩🇪Researchcharite.de

Campus Charité Mitte: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source
🇩🇪Researchcharite.de

Campus Berlin Buch: Charité – Universitätsmedizin Berlin

Charité Mitte (Berlin)Original source